Tru Independence LLC Sangamo Therapeutics, Inc Transaction History

Tru Independence LLC

  • $310 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 20, 2021
SELL
$10.88 - $17.05 $15,232 - $23,870
-1,400 Closed
0 $0
Q4 2020

Mar 09, 2021
BUY
$9.23 - $18.18 $12,922 - $25,452
1,400 New
1,400 $21,000
Q3 2020

Nov 19, 2020
SELL
$9.38 - $12.48 $9,380 - $12,480
-1,000 Closed
0 $0
Q4 2019

May 19, 2020
BUY
$8.03 - $11.7 $8,029 - $11,700
1,000 New
1,000 $6,000

Others Institutions Holding SGMO

# of Institutions
141
Shares Held
60.4M
Call Options Held
1.46M
Put Options Held
1.84M
View Full List

About SANGAMO THERAPEUTICS, INC

SGMO Quotes by TradingView
  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $144M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Tru Independence LLC Portfolio

Follow Tru Independence LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tru Independence LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tru Independence LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email